In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: Results from a multicenter surveillance study

Japanese Journal of Infectious Diseases

Volumn 65, Issue 6, 2012, Pages 535-538

  Akaike, Hiroto ^a   Miyashita, Naoyuki ^a   Kubo, Mika ^a   Kawai, Yasuhiro ^a   Tanaka, Takaaki ^a   Ogita, Satoko ^a   Kawasaki, Kozo ^a   Nakano, Takashi ^a   Terada, Kihei ^a   Ouchi, Kazunobu ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; GARENOXACIN; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; MOXIFLOXACIN; RNA 23S; ROKITAMYCIN; TETRACYCLINE; TOSUFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DRUG POTENCY; FEMALE; HUMAN; IN VITRO STUDY; JAPAN; MACROLIDE RESISTANT MYCOPLASMA PNEUMONIAE; MACROLIDE SENSITIVE MYCOPLASMA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIAE; NONHUMAN; PROSPECTIVE STUDY; SCHOOL CHILD;

ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; JAPAN; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA INFECTIONS; MYCOPLASMA PNEUMONIAE; POINT MUTATION; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S;

EID: 84869858478     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.65.535     Document Type: Article

References (19)

1. Morozumi, M., Takahashi, T. and Ubukata, K. (2010): Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J. Infect. Chemother., 16, 78-86.
2. Kawai, Y., Miyashita, N., Yamaguchi, T., et al. (2012): Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Respirology, 17, 354-362.
3. Averbuch, D., Hidalgo-Grass, C., Moses, A.E., et al. (2011): Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg. Infect. Dis., 17, 1079-1082.
4. Chironna, M., Sallustio, A., Esposito, S., et al. (2011): Emer gence of macrolide-resistant isolates during an outbreak of Mycoplasma pneumoniae infections in children. J. Antimicrob. Chemother., 66, 734-737.
5. Dumke, R., von Baum, H., Luck, P.C., et al. (2010): Occurrence of macrolide-resistant Mycoplasma pneumoniae strain in Germany. Clin. Microbiol. Infect., 16, 613-616.
6. Lin, Y., Ye, X., Zhang, H., et al. (2010): Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn. Microbiol. Infect. Dis., 67, 355-358.
7. Peuchant, O., Menard, A., Renaudin, H., et al. (2009): Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J. Antimicrob. Chemother., 64, 52-58.
8. Wolff, B.J., Thacker, W.L., Schwartz, S.B., et al. (2008): Detection of macrolide resistance in Mycoplasma pneumoniae by realtime PCR and high-resolution melt analysis. Antimicrob. Agents Chemother., 52, 3542-3549.
9. Cao, B., Zhao, C.J., Yin, Y.D., et al. (2010): High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin. Infect. Dis., 51, 189-194.
10. Okazaki, N., Narita, M., Yamada, S., et al. (2001): Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol. Immunol., 45, 617-620.
11. Matsuoka, M., Narita, M., Okazaki, N., et al. (2004): Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother., 48, 4624-4630.
12. Matsubara, K., Morozumi, M., Okada, T., et al. (2009): A comparative clinical study of macrolide-sensitive and macrolideresistant Mycoplasma pneumoniae infections in pediatric patients. J. Infect. Chemother., 15, 380-383.
13. Suzuki, S., Yamazaki, T., Narita, M., et al. (2006): Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob. Agents Chemother., 50, 709-712.
14. Waites, K.B., Crabb, D.M., Bing, X., et al. (2003): In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob. Agents Chemother., 47, 161-165.
15. Candinale, F., Chironna, M., Dumke, R., et al. (2011): Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia. Eur. Respir. J., 37, 1522-1533.
16. Ouchi, K., Kurosaki, T. and Okada, K. (eds.) (2011): The Committee for the Guidelines in Management of Respiratory Infectious Diseases in Children. Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan, 2011. Japanese Society of Pediatric Pulmonology/Japanese Society for Pediatric Infectious Diseases, Tokyo (in Japanese).
17. Ishida, K., Kaku, M., Irifune, K., et al. (1994): In-vitro and invivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniae. J. Antimicrob. Chemother., 34, 875-883.
18. Niki, Y., Hanaki, H., Matsumoto, T., et al. (2011): Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008: general view of the pathogens' antibacterial susceptibility. J. Infect. Chemother., 17, 510-523.
19. Inoue, M., Yamaguchi, T., Saito, A., et al. (2011): Clinical study of macrolide-resistant Mycoplasma pneumoniae using PCR. Abstract. p. 150 (in Japanese). 59th Annual Meeting of Japan Society for Chemotherapy, Sappro, 2011.